Merriman Wealth Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,000
Closed -$44.3K 212
2023
Q1
$44.3K Hold
13,000
﹤0.01% 194
2022
Q4
$36.1K Sell
13,000
-53,000
-80% -$158K ﹤0.01% 206
2022
Q3
$189K Hold
66,000
0.01% 168
2022
Q2
$229K Hold
66,000
0.02% 150
2022
Q1
$311K Hold
66,000
0.03% 160
2021
Q4
$399K Hold
66,000
0.03% 157
2021
Q3
$400K Hold
66,000
0.03% 152
2021
Q2
$826K Hold
66,000
0.07% 126
2021
Q1
$680K Hold
66,000
0.08% 109
2020
Q4
$600K Buy
+66,000
New +$475K 0.06% 133
2018
Q4
Sell
-191,208
Closed -$1.18M 198
2018
Q3
$1.18M Buy
191,208
+13,300
+7% +$60.1K 0.25% 65
2018
Q2
$1.14M Buy
177,908
+17,750
+11% +$126K 0.26% 65
2018
Q1
$1.12M Buy
160,158
+4,273
+3% +$49.8K 0.29% 74
2017
Q4
$1.97M Sell
155,885
-17,314
-10% -$211K 0.48% 53
2017
Q3
$2.06M Sell
173,199
-233,605
-57% -$3.46M 0.49% 53
2017
Q2
$6.09M Sell
406,804
-158,525
-28% -$2.12M 1.7% 16
2017
Q1
$5.39M Sell
565,329
-7,315
-1% -$61.8K 1.31% 25
2016
Q4
$5.07M Sell
572,644
-17,176
-3% -$154K 1.39% 21
2016
Q3
$5.06M Sell
589,820
-32,854
-5% -$260K 1.04% 34
2016
Q2
$4.97M Buy
+622,674
New +$4.85M 1.4% 22

Other funds holding MDXG

Merriman Wealth Management's MDXG Position: Q2 2023 in Review

Merriman Wealth Management sold out of MiMedx Group (MDXG) in Q2 2023, closing a stake of 13,000 shares — an estimated $44.3K sold.

Merriman Wealth Management first reported a position in MDXG in Q2 2016 and held it in 20 quarters. The position peaked at $6.09M in Q2 2017. 177 funds tracked by Wall St. Rank hold MDXG as of Q2 2023.

  • Merriman Wealth Management reported no remaining MiMedx Group position as of Q2 2023 after selling out during the quarter.
  • Merriman Wealth Management sold 13,000 MiMedx Group shares in Q2 2023, an estimated $44.3K.
  • Merriman Wealth Management first reported a position in MiMedx Group in Q2 2016 and held it in 20 quarters.
  • Merriman Wealth Management's MiMedx Group position peaked at $6.09M in Q2 2017.
  • 177 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2023.

Based on Merriman Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.